|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,016.00 CHF | -0.97% |
|
-7.64% | +18.21% |
| 12-06 | Siegfried Names Chief Scientific, Human Resources, Legal & Sustainability Officers | MT |
| 11-19 | Global markets live: Alphabet, Nvidia, Tesla, Nestlé, ThyssenKrupp... |  |
| Capitalization | 4.4B 5.02B 4.74B 3.92B 7.09B 426B 7.77B 54.71B 20.2B 175B 18.85B 18.44B 758B | P/E ratio 2024 * |
28.9x | P/E ratio 2025 * | 25.3x |
|---|---|---|---|---|---|
| Enterprise value | 4.76B 5.43B 5.14B 4.25B 7.67B 461B 8.41B 59.22B 21.86B 189B 20.4B 19.96B 821B | EV / Sales 2024 * |
3.65x | EV / Sales 2025 * | 3.36x |
| Free-Float |
-
| Yield 2024 * |
0.37% | Yield 2025 * | 0.39% |
More valuation ratios
* Estimated data
More news
Last Transcript: Siegfried Holding AG
More recommendations
More press releases
More news
| 1 day | -4.11% | ||
| 1 week | -6.73% | ||
| Current month | -7.90% | ||
| 1 month | -9.20% | ||
| 3 months | -9.36% | ||
| 6 months | +10.44% | ||
| Current year | +19.37% |
1 week
1 024.00
1 112.00
1 month
1 024.001 144.00
Current year
827.001 188.00
1 year
795.001 188.00
3 years
566.001 188.00
5 years
313.501 188.00
10 years
139.501 188.00
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 31/08/2024 | |
Reto Suter
CEO | Chief Executive Officer | 53 | 30/04/2024 |
Jürgen Roos
CTO | Chief Tech/Sci/R&D Officer | 56 | 31/03/2019 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andreas Casutt
CHM | Chairman | 61 | 23/03/2014 |
Wolfram Carius
BRD | Director/Board Member | 63 | 31/12/2013 |
Martin Schmid
BRD | Director/Board Member | 55 | 31/12/2015 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.02% | 10 M€ | -3.35% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -4.11% | -6.73% | +28.17% | +17.12% | 5.02B | ||
| -2.80% | +0.47% | +34.37% | +230.83% | 724B | ||
| -0.41% | +0.84% | +17.01% | +108.39% | 491B | ||
| +0.19% | -3.36% | -3.12% | -9.83% | 360B | ||
| +0.22% | -2.86% | +18.28% | +42.22% | 312B | ||
| +0.68% | +3.16% | +0.04% | +42.45% | 263B | ||
| +0.08% | +0.39% | +1.54% | -31.25% | 236B | ||
| +0.45% | +1.40% | +5.73% | +27.98% | 212B | ||
| -0.48% | -4.04% | +5.50% | +19.75% | 204B | ||
| +1.85% | -0.17% | +3.16% | +30.61% | 149B | ||
| Average | -0.70% | -1.44% | +11.07% | +47.83% | 295.52B | |
| Weighted average by Cap. | -0.80% | -0.52% | +13.91% | +84.02% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 1.31B 1.49B 1.41B 1.16B 2.1B 126B 2.3B 16.24B 6B 51.87B 5.59B 5.47B 225B | 1.4B 1.6B 1.51B 1.25B 2.26B 136B 2.47B 17.41B 6.43B 55.62B 6B 5.87B 241B |
| Net income | 152M 174M 164M 136M 245M 14.75B 269M 1.89B 699M 6.05B 653M 638M 26.25B | 174M 198M 188M 155M 280M 16.84B 307M 2.16B 799M 6.91B 745M 729M 29.98B |
| Net Debt | 363M 414M 392M 324M 585M 35.15B 641M 4.52B 1.67B 14.42B 1.56B 1.52B 62.56B | 309M 353M 333M 276M 498M 29.91B 545M 3.84B 1.42B 12.27B 1.32B 1.29B 53.24B |
More financial data
* Estimated data
Employees
3,797
Sector
Pharmaceuticals
Calendar
17/02/2025
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/24 | 1,016.00 CHF | -0.97% | 12,192 |
| 09/12/24 | 1,026.00 CHF | -4.11% | 13,157 |
| 06/12/24 | 1,070.00 CHF | -0.74% | 5,120 |
| 05/12/24 | 1,078.00 CHF | -2.53% | 6,333 |
| 04/12/24 | 1,106.00 CHF | 0.00% | 6,788 |
Delayed Quote Swiss Exchange, December 09, 2024 at 04:30 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
1,026.00CHF
Average target price
1,187.67CHF
Spread / Average Target
+15.76%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SFZN Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition